Siemens Healthineers AG (OTCMKTS:SMMNY) Given Consensus Rating of “Strong Buy” by Analysts

Siemens Healthineers AG (OTCMKTS:SMMNY) has earned an average rating of “Strong Buy” from the six ratings firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating, one has issued a buy rating and four have assigned a strong buy rating to the company.

SMMNY has been the topic of a number of analyst reports. DZ Bank upgraded shares of Siemens Healthineers from a “hold” rating to a “strong-buy” rating in a research report on Friday, May 16th. Hsbc Global Res upgraded shares of Siemens Healthineers from a “hold” rating to a “strong-buy” rating in a research report on Friday, April 25th. HSBC upgraded shares of Siemens Healthineers to a “buy” rating in a research report on Friday, April 25th. Finally, Berenberg Bank upgraded shares of Siemens Healthineers to a “strong-buy” rating in a research report on Thursday, January 30th.

Siemens Healthineers Price Performance

Siemens Healthineers stock opened at $26.96 on Wednesday. Siemens Healthineers has a twelve month low of $23.28 and a twelve month high of $30.19. The company’s 50-day moving average price is $26.28 and its two-hundred day moving average price is $27.18.

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems.